Missed the live session? This webinar is now available to watch on demand.
As emerging therapeutic modalities continue to evolve, analytical strategies must keep pace. This session explores how legacy analytical technologies, particularly mass spectrometry and higher-order structural techniques are being adapted to support modern biopharmaceutical development.
The development of complex biopharmaceuticals increasingly relies on robust analytical characterization strategies. Regulatory expectations emphasize the need for comprehensive structural and physicochemical analysis, particularly in demonstrating comparability across products.
In this webinar, our speaker, Christopher Ziegenfuss, Vice President at BioPharmaSpec Inc, offers valuable insight into how these techniques continue to address current challenges in therapeutic discovery, development, and manufacturing.
The webinar highlights how modern advancements are enabling legacy technologies to remain relevant, robust, and effective in supporting increasingly complex biopharmaceutical products.
